{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:47:28Z","timestamp":1792795648234,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nasopharyngeal cancer (NPC), endemic in Southeast Asia, lacks effective diagnostic and therapeutic strategies. Even in high-income countries the 5-year survival rate for stage IV NPC is less than 40%. Here we report high somatostatin receptor 2 (SSTR2) expression in multiple clinical cohorts comprising 402 primary, locally recurrent and metastatic NPCs. We show that SSTR2 expression is induced by the Epstein\u2013Barr virus (EBV) latent membrane protein 1 (LMP1) via the NF-\u03baB pathway. Using cell-based and preclinical rodent models, we demonstrate the therapeutic potential of SSTR2 targeting using a cytotoxic drug conjugate, PEN-221, which is found to be superior to FDA-approved SSTR2-binding cytostatic agents. Furthermore, we reveal significant correlation of SSTR expression with increased rates of survival and report in vivo uptake of the SSTR2-binding\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-peptide radioconjugate in PET-CT scanning in a clinical trial of NPC patients (NCT03670342). These findings reveal a key role in EBV-associated NPC for SSTR2 in infection, imaging, targeted therapy and survival.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-20308-8","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T06:07:08Z","timestamp":1609826828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-0773","authenticated-orcid":false,"given":"Matt","family":"Lechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-7644","authenticated-orcid":false,"given":"Volker H.","family":"Schartinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6027-1652","authenticated-orcid":false,"given":"Wen Long","family":"Nei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Lucas","family":"Ooft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesa-Marie","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos P.","family":"Pipinikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Tin-Yun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-3707","authenticated-orcid":false,"given":"Ka-Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Man","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Philpott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Nibhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-1242","authenticated-orcid":false,"given":"Christopher G.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Delecluse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-8022","authenticated-orcid":false,"given":"Yim Ling","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyn","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-2056","authenticated-orcid":false,"given":"Cillian T.","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Dud\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Krapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Uprimny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-8233","authenticated-orcid":false,"given":"Tim R.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Chester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Thirlwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Royle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Marafioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-0505","authenticated-orcid":false,"given":"Rajeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagung Rai","family":"Indrasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Herdini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-1304","authenticated-orcid":false,"given":"Mohd Afiq Mohd","family":"Slim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Indrawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"Fles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Yeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-974X","authenticated-orcid":false,"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin S. H.","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua K.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Wah","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-5342","authenticated-orcid":false,"given":"Udo","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1744-6274","authenticated-orcid":false,"given":"Henri-Jacques","family":"Delecluse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-1473","authenticated-orcid":false,"given":"Melvin L. K.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-3400","authenticated-orcid":false,"given":"Pierre","family":"Busson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-6124","authenticated-orcid":false,"given":"Kwok Wai","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Wollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-4105","authenticated-orcid":false,"given":"Nischalan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7074-3673","authenticated-orcid":false,"given":"Bart","family":"Vanhaesebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie J.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"20308_CR1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua, M. L. K., Wee, J. T. S., Hui, E. P. & Chan, A. T. C. Nasopharyngeal carcinoma. Lancet 387, 1012\u20131024 (2016).","journal-title":"Lancet"},{"key":"20308_CR2","unstructured":"Shanmugaratnam, K., Sobin, L. H. & World Health Organization. Histological Typing of Upper Respiratory Tract Tumors (World Health Organization, Geneva, 1978)."},{"key":"20308_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2217\/fon-2016-0410","volume":"13","author":"JW Chan","year":"2017","unstructured":"Chan, J. W., Parvathaneni, U. & Yom, S. S. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma. Future Oncol. 13, 425\u2013431 (2017).","journal-title":"Future Oncol."},{"key":"20308_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/COC.0b013e31820dbdcc","volume":"35","author":"B You","year":"2012","unstructured":"You, B. et al. A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and\/or metastatic nasopharyngeal carcinoma. Am. J. Clin. Oncol. 35, 255\u2013260 (2012).","journal-title":"Am. J. Clin. Oncol."},{"key":"20308_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel, M. et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J. Nucl. Med. 48, 508\u2013518 (2007).","journal-title":"J. Nucl. Med."},{"key":"20308_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1023\/A:1008383132024","volume":"11","author":"S Ricci","year":"2000","unstructured":"Ricci, S. et al. Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide. Ann. Oncol. 11, 1127\u20131130 (2000).","journal-title":"Ann. Oncol."},{"key":"20308_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin, M. E. et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N. Engl. J. Med. 371, 224\u2013233 (2014).","journal-title":"N. Engl. J. Med."},{"key":"20308_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-014-2905-5","volume":"42","author":"VH Schartinger","year":"2015","unstructured":"Schartinger, V. H. et al. (68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma. Eur. J. Nucl. Med. Mol. Imaging 42, 20\u201324 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"20308_CR9","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1002\/hed.24164","volume":"38","author":"LK Khor","year":"2016","unstructured":"Khor, L. K. et al. (68)Ga-DOTA-peptide: a novel molecular biomarker for nasopharyngeal carcinoma. Head Neck 38, E76\u2013E80 (2016).","journal-title":"Head Neck"},{"key":"20308_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/RLU.0000000000001985","volume":"43","author":"M Unterrainer","year":"2018","unstructured":"Unterrainer, M. et al. 68Ga-DOTATATE PET\/CT reveals Epstein-Barr virus-associated nasopharyngeal carcinoma in a case of suspected sphenoid wing meningioma. Clin. Nucl. Med. 43, 287\u2013288 (2018).","journal-title":"Clin. Nucl. Med."},{"key":"20308_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00428-002-0693-y","volume":"441","author":"KS Loh","year":"2002","unstructured":"Loh, K. S. et al. Somatostatin receptors in nasopharyngeal carcinoma. Virchows Arch. 441, 444\u2013448 (2002).","journal-title":"Virchows Arch."},{"key":"20308_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14121","volume":"8","author":"YY Li","year":"2017","unstructured":"Li, Y. Y. et al. Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations. Nat. Commun. 8, 14121 (2017).","journal-title":"Nat. Commun."},{"key":"20308_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/path.4239","volume":"231","author":"GT Chung","year":"2013","unstructured":"Chung, G. T. et al. Constitutive activation of distinct NF-kappaB signals in EBV-associated nasopharyngeal carcinoma. J. Pathol. 231, 311\u2013322 (2013).","journal-title":"J. Pathol."},{"key":"20308_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/path.5130","volume":"246","author":"AK Lo","year":"2018","unstructured":"Lo, A. K. et al. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. J. Pathol. 246, 180\u2013190 (2018).","journal-title":"J. Pathol."},{"key":"20308_CR15","first-page":"339","volume":"390","author":"N Raab-Traub","year":"2015","unstructured":"Raab-Traub, N. Nasopharyngeal carcinoma: an evolving role for the Epstein-Barr virus. Curr. Top. Microbiol. Immunol. 390, 339\u2013363 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"20308_CR16","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/1541-7786.MCR-17-0134","volume":"15","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes. Mol. Cancer Res. 15, 1722\u20131732 (2017).","journal-title":"Mol. Cancer Res."},{"key":"20308_CR17","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1158\/1055-9965.EPI-06-0455","volume":"15","author":"LE Dodd","year":"2006","unstructured":"Dodd, L. E. et al. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 15, 2216\u20132225 (2006).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"20308_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F","volume":"83","author":"ST Cheung","year":"1999","unstructured":"Cheung, S. T. et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83, 121\u2013126 (1999).","journal-title":"Int. J. Cancer"},{"key":"20308_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06889-5","volume":"9","author":"W Lin","year":"2018","unstructured":"Lin, W. et al. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nat. Commun. 9, 4663 (2018).","journal-title":"Nat. Commun."},{"key":"20308_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.2910420422","volume":"42","author":"P Busson","year":"1988","unstructured":"Busson, P. et al. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer 42, 599\u2013606 (1988).","journal-title":"Int. J. Cancer"},{"key":"20308_CR21","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1200\/JCO.2018.36.15_suppl.4097","volume":"36","author":"ML Johnson","year":"2018","unstructured":"Johnson, M. L. & Meyer, T. First in human phase 1\/2a study of PEN-221 somatostatin analog (SSA)-DM1 conjugate for patients (PTS) with advanced neuroendocrine tumor (NET) or small cell lung cancer (SCLC): phase 1 results. J. Clin. Oncol. 36, 4097\u20134097 (2018).","journal-title":"J. Clin. Oncol."},{"key":"20308_CR22","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1021\/acs.jmedchem.8b02036","volume":"62","author":"BH White","year":"2019","unstructured":"White, B. H. et al. Discovery of an SSTR2-targeting maytansinoid conjugate (PEN-221) with potent activity in vitro and in vivo. J. Med. Chem. 62, 2708\u20132719 (2019).","journal-title":"J. Med. Chem."},{"key":"20308_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1517\/13543780903176399","volume":"18","author":"P Msaouel","year":"2009","unstructured":"Msaouel, P., Galanis, E. & Koutsilieris, M. Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology. Expert Opin. Invest. Drugs 18, 1297\u20131316 (2009).","journal-title":"Expert Opin. Invest. Drugs"},{"key":"20308_CR24","unstructured":"Neidle, S. Cancer Drug Design and Discovery (Elsevier\/Academic Press, Amsterdam, 2014)."},{"key":"20308_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","volume":"22","author":"A Hildesheim","year":"2012","unstructured":"Hildesheim, A. & Wang, C. P. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin. Cancer Biol. 22, 107\u2013116 (2012).","journal-title":"Semin. Cancer Biol."},{"key":"20308_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/scbi.1996.0023","volume":"7","author":"G Niedobitek","year":"1996","unstructured":"Niedobitek, G., Agathanggelou, A. & Nicholls, J. M. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Semin. Cancer Biol. 7, 165\u2013174 (1996).","journal-title":"Semin. Cancer Biol."},{"key":"20308_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0174-3","volume":"36","author":"SK Yong","year":"2017","unstructured":"Yong, S. K. et al. Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case-control study. Chin. J. Cancer 36, 3 (2017).","journal-title":"Chin. J. Cancer"},{"key":"20308_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.oraloncology.2014.02.006","volume":"50","author":"SW Tsao","year":"2014","unstructured":"Tsao, S. W. et al. Etiological factors of nasopharyngeal carcinoma. Oral. Oncol. 50, 330\u2013338 (2014).","journal-title":"Oral. Oncol."},{"key":"20308_CR29","first-page":"1077","volume":"37","author":"X Tang","year":"2010","unstructured":"Tang, X. et al. Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma. Int. J. Oncol. 37, 1077\u20131083 (2010).","journal-title":"Int. J. Oncol."},{"key":"20308_CR30","first-page":"149","volume":"26","author":"C Casini Raggi","year":"2001","unstructured":"Casini Raggi, C. et al. Somatostatin receptors in non-endocrine tumours. Minerva Endocrinol. 26, 149\u2013158 (2001).","journal-title":"Minerva Endocrinol."},{"key":"20308_CR31","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","volume":"388","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet 388, 1883\u20131892 (2016).","journal-title":"Lancet"},{"key":"20308_CR32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hed.23716","volume":"37","author":"R Noorlag","year":"2015","unstructured":"Noorlag, R. et al. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2. Head Neck 37, 1130\u20131136 (2015).","journal-title":"Head Neck"},{"key":"20308_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4132\/KoreanJPathol.2014.48.5.351","volume":"48","author":"SJ Choi","year":"2014","unstructured":"Choi, S. J. et al. Preparation of compact agarose cell blocks from the residues of liquid-based cytology samples. Korean J. Pathol. 48, 351\u2013360 (2014).","journal-title":"Korean J. Pathol."},{"key":"20308_CR34","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/ijms19061771","volume":"19","author":"J Dudas","year":"2018","unstructured":"Dudas, J. et al. Nerve growth factor (NGF)-receptor survival axis in head and neck squamous cell carcinoma. Int. J. Mol. Sci. 19, 1771 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"20308_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1158\/1535-7163.MCT-19-0022","volume":"18","author":"KA Whalen","year":"2019","unstructured":"Whalen, K. A. et al. Targeting the somatostatin receptor 2 with the miniaturized drug conjugate, PEN-221: a potent and novel therapeutic for the treatment of small cell lung cancer. Mol. Cancer Ther. 18, 1926\u20131936 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"20308_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u201341 (2017).","journal-title":"Nat. Methods"},{"key":"20308_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"20308_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"GC Yu","year":"2012","unstructured":"Yu, G. C., Wang, L. G., Han, Y. Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"20308_CR39","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 46, D649\u2013D655 (2018).","journal-title":"Nucleic Acids Res."},{"key":"20308_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20308-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:51:27Z","timestamp":1669956687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20308-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20308"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20308-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.V. is a consultant for Venthera (Palo Alto, US), iOnctura (Geneva, Switzerland) and Karus Therapeutics, Oxford, UK and has received speaker\u2019s fees from Gilead (Foster City, US). T.Me. has acted as a consultant for Tarveda Therapeutics (Watertown, MA, US). G.W. serves as a scientific advisor to ViraTherapeutics and Boehringer Ingelheim. S.M. receives research grants from Pfizer, Bayer, MSD, AstraZeneca, Nextcure, Roche, BMS, Amgen and Lily. M.C. reports personal fees from Astellas, personal fees from Janssen, grants and personal fees from Ferring, personal fees from MSD Oncology, personal fees from Illumina, nonfinancial support from AstraZeneca, personal fees and nonfinancial support from Varian, nonfinancial support from GenomeDx Biosciences, nonfinancial support from Medlever, outside the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}